Almotriptan adverse reactions

Revision as of 02:07, 5 February 2014 by Pratik Bahekar (talk | contribs)
Jump to navigation Jump to search
Almotriptan
AXERT® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials on Almotriptan
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Pratik Bahekar, MBBS [2]

Adverse Reactions

The most common adverse reactions (≥1% and greater than placebo) are:

  • In adults: nausea, dry mouth and paresthesia
  • In adolescents: dizziness, somnolence, headache, paresthesia, nausea and vomiting


References